{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-021470","form_type":"8-K","ticker":"AURX","cik":"0001091596","company_name":"Nuo Therapeutics, Inc.","filed_at":"2022-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.955586+00:00","generated_at":"2026-06-23T19:11:43.506512+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nuo Therapeutics secures $500K equity investment from distributor Pacific Medical; raises $4.5M YTD","bullets":["PacMed invests $500K for 500K shares at $1.00; receives two warrants for up to 450K shares tied to sales quotas.","PacMed can earn up to 300K milestone shares if cumulative sales reach $4.5M–$12.5M over 2024–2025 periods.","Company raised ~$4.5M in working capital equity in 2022, including this deal, to support Aurix commercial re-launch.","Distribution network covers ~30% of U.S. population via 10 entities; PacMed contributes over 40 sales representatives.","Stock approved for OTCQB trading; uplisting to national securities exchange considered as a future option."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-021470","json":"https://secwatch.observer/filing/0001437749-22-021470.json","markdown":"https://secwatch.observer/filing/0001437749-22-021470.md","text":"https://secwatch.observer/filing/0001437749-22-021470.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/0001437749-22-021470-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922021470/aurx20220824b_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T19:11:43.506512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}